January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Kringle Pharma, Inc.
A late clinical-stage biopharmaceutical company focused on developing recombinant human HGF, KP-100, for the treatment of acute spinal cord injury, vocal fold scar and ALS.
)
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)